Phoenix, July 18, 2017 (GLOBE NEWSWIRE) — / FOR IMMEDIATE RELEASE — BioNovelus (ONOV) CEO and Founder, Jean Ekobo, took a prominent role in the First World Coffee Producers Forum in Medellin, Colombia, July 10 to 12.
The forum was organized by a conglomerate of coffee producing countries. It brought together key players from the coffee production chain including exporters, importers, roasters, and traders from the global industry with representation from 45 coffee producing countries including Colombia, Brazil, Costa Rica, Guatemala, Honduras, Peru, Ecuador, Mexico, and others. In addition, the event was attended by key players in the coffee industry from around the world.
Attending dignitaries included President Bill Clinton, the Nobel Prize-winning President of Colombia, Juan Manuel Santos, President of Costa Rica, Luis Guillermo Solís, President of Honduras, Juan Orlando Hernandez, Executive Director of the International Coffee Organization (ICO), José Sette; and the CEO of the Colombian Coffee Growers Federation (FNC), Roberto Velez, as well as representatives of African, Asian and Latin American coffee producers, and coffee roasters such as Starbucks, Nestlé, and Walmart.
“As the company’s stature grows, it becomes ever more important for BioNovelus to take part in coffee-focused events on a global scale,” says Ekobo. “We are anticipating taking an increasingly vital role in securing the future of coffee, worldwide.”
BioNovelus is a biotech company that honors the environment with innovative, cost effective, and disruptive technology-based solutions to crop protection, food security, and health challenges.
This news release includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties and actual results for the fiscal year 2017 and beyond could differ materially from the Company’s current expectations. Forward-looking statements are identified by words such as “anticipates,” “projects,” “expects,” “plans,” “intends,” “believes,” “estimates,” “targets,” and other similar expressions that indicate trends and future events. The Company undertakes no obligation to revise or update forward-looking statements because of new information, since these statements may no longer be accurate or timely.
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this press release, including, without limitation, statements regarding potential plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.
— 30 —
For more information, contact http://bionovelus.com
Marketing Communications Director
+1 602-888-3424 ext.1
Anthony J. Parkinson,
Chief Information Officer
+1 602-888-3424 ext.3
Media contact: Nathalie Ekobo, Marketing Communications Director BioNovelus, Inc. +1 602-888-3424 ext.1 Info@BioNovelus.com Investor Relations: Anthony J. Parkinson, Chief Information Officer BioNovelus, Inc. +1 602-888-3424 ext.3 Investor.Relations@BioNovelus.com